Aromatase Inhibitors May Benefit Premenopausal Women With Breast Cancer

FRIDAY, Feb. 11, 2022 -- For premenopausal women with estrogen receptor (ER)-positive breast cancer receiving ovarian suppression, use of an aromatase inhibitor rather than tamoxifen is associated with a reduced risk for recurrence, according to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news